Healthpeak Properties, Inc. (NYSE:PEAK) Stock Position Decreased by Vanderbilt University

Vanderbilt University cut its stake in shares of Healthpeak Properties, Inc. (NYSE:PEAKFree Report) by 25.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,005 shares of the company’s stock after selling 3,672 shares during the quarter. Vanderbilt University’s holdings in Healthpeak Properties were worth $218,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Norges Bank acquired a new stake in shares of Healthpeak Properties in the fourth quarter worth $386,590,000. Invesco Ltd. boosted its position in shares of Healthpeak Properties by 96.4% in the first quarter. Invesco Ltd. now owns 11,512,029 shares of the company’s stock worth $395,209,000 after buying an additional 5,650,120 shares during the period. State Street Corp boosted its position in shares of Healthpeak Properties by 8.8% in the first quarter. State Street Corp now owns 38,709,498 shares of the company’s stock worth $1,328,897,000 after buying an additional 3,142,939 shares during the period. Centersquare Investment Management LLC boosted its position in shares of Healthpeak Properties by 38.4% in the second quarter. Centersquare Investment Management LLC now owns 9,149,325 shares of the company’s stock worth $183,901,000 after buying an additional 2,539,759 shares during the period. Finally, Eaton Vance Management boosted its position in shares of Healthpeak Properties by 226.9% in the first quarter. Eaton Vance Management now owns 3,616,528 shares of the company’s stock worth $124,156,000 after buying an additional 2,510,133 shares during the period. 92.55% of the stock is owned by institutional investors.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock traded up $0.35 during trading on Wednesday, reaching $17.10. The company’s stock had a trading volume of 9,979,100 shares, compared to its average volume of 7,814,412. The business’s fifty day moving average price is $17.99 and its 200-day moving average price is $18.20. Healthpeak Properties, Inc. has a one year low of $15.24 and a one year high of $24.46. The firm has a market cap of $9.36 billion, a price-to-earnings ratio of 30.54, a price-to-earnings-growth ratio of 4.00 and a beta of 1.01. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.67 and a current ratio of 0.67.

Healthpeak Properties (NYSE:PEAKGet Free Report) last released its earnings results on Thursday, February 8th. The company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.32). Healthpeak Properties had a net margin of 13.97% and a return on equity of 4.34%. The business had revenue of $553.65 million during the quarter, compared to analyst estimates of $553.77 million. During the same period last year, the business earned $0.44 EPS. The business’s quarterly revenue was up 5.6% compared to the same quarter last year. As a group, equities research analysts predict that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 26th. Shareholders of record on Wednesday, February 14th were given a $0.30 dividend. The ex-dividend date of this dividend was Tuesday, February 13th. This represents a $1.20 annualized dividend and a yield of 7.02%. Healthpeak Properties’s payout ratio is 214.29%.

Analysts Set New Price Targets

PEAK has been the subject of a number of research reports. Scotiabank reduced their price objective on Healthpeak Properties from $23.00 to $22.00 and set a “sector outperform” rating for the company in a research report on Monday, March 4th. Deutsche Bank Aktiengesellschaft initiated coverage on Healthpeak Properties in a research report on Tuesday, January 30th. They set a “hold” rating and a $21.00 price objective for the company. Finally, BNP Paribas raised Healthpeak Properties from an “underperform” rating to a “neutral” rating and set a $19.00 price objective for the company in a research report on Monday, February 12th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $23.05.

Check Out Our Latest Stock Report on PEAK

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, Director Sara Grootwassink Lewis bought 18,000 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was purchased at an average cost of $16.71 per share, with a total value of $300,780.00. Following the completion of the purchase, the director now owns 22,000 shares in the company, valued at $367,620. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.19% of the stock is currently owned by corporate insiders.

Healthpeak Properties Profile

(Free Report)

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

Featured Stories

Want to see what other hedge funds are holding PEAK? Visit to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:PEAKFree Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:PEAK)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with's FREE daily email newsletter.